Science Explorer Back to mapMap
Discussion
Researcher · University of Toronto · Canada

Andrew C. Wakeham

Andrew C. Wakeham publishes mostly in Molecular Biology, Immunology and Oncology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and NF-κB Signaling Pathways.

OpenAlex
World rank
#15,092
of 7,710,434 ranked researchers
Rank in Canada
#299
of 183,316
Works
160
Citations
47k
Citations per work
292.4
h-index
88
i10-index 135Top 0.4% in Molecular Biology
Andrew C. Wakeham

What does Andrew C. Wakeham research?

Andrew C. Wakeham's work is mostly in Biochemistry, Genetics and Molecular Biology (39%), Immunology and Microbiology (24%), Medicine (13%).

Life Sciences: 101 works · 63.4% of their workBiochemistry, Genetics and Molecular Biology: 63 works · 39.3% of their workMolecular Biology: 47 works · 29.3% of their workCancer Research: 12 works · 7.2% of their workCell Biology: 4 works · 2.8% of their workImmunology and Microbiology: 39 works · 24.1% of their workImmunology: 39 works · 24.1% of their workEverything else: 38 works · 24.0% of their workHealth Sciences: 20 works · 12.6% of their workMedicine: 20 works · 12.6% of their workOncology: 16 works · 9.8% of their workHematology: 4 works · 2.8% of their workTHEIR WORKAndrew C. Wakeham160works
Life Sciences63%Health Sciences13%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology6339.3%
    2. Immunology and Microbiology3924.1%
  2. Everything else3824.0%
    1. Medicine2012.6%
  1. 1Molecular Biology29% of their works
  2. 2Immunology24% of their works
  3. 3Oncology10% of their works
  4. 4Cancer Research7% of their works
  5. 5Cell Biology3% of their works
  6. 6Hematology3% of their works

Research topics

Which keywords describe Andrew C. Wakeham's research?

The keywords of their largest research topics: Immunity, Inflammation, Regulation, Cancer, Apoptosis, Cancer Therapy, Natural Killer Cells and NK Cell Recognition.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Immunity382 topics
  2. Inflammation362 topics
  3. Regulation362 topics
  4. Cancer342 topics
  5. Apoptosis302 topics
  6. Cancer Therapy302 topics
  7. NK Cell Recognition251 topic
  8. Natural Killer Cells251 topic
  9. Foxp3211 topic
  10. TGF-ß211 topic
  11. Cancer Immunotherapy191 topic
  12. Dendritic Cells191 topic
  13. NF-?B191 topic
  14. Signaling191 topic
  15. Cell Cycle171 topic
  16. Pattern Recognition Receptors171 topic
  17. Toll-like Receptors171 topic
  18. p53171 topic
  19. DNA Damage151 topic
  20. Repair151 topic
  21. Bcl-2 Family131 topic
  22. Cell Death131 topic

Where does Andrew C. Wakeham work?

Andrew C. Wakeham's main affiliation in the publication record is University of Toronto, Canada.

How many publications and citations does Andrew C. Wakeham have?

OpenAlex counts 160 works and 46,781 citations for Andrew C. Wakeham, an h-index of 88, ranking #15,092 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Andrew C. Wakeham. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.